Investigational drug · Phase 2
TRX-100
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Influenza.
Phase 2Last checked: Nov 19, 2026Latest source record: Mar 31, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
4
Any phase or sponsor naming "TRX-100"
First trial start
2025
Dec 15, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "TRX-100", any sponsor or status.
Conditions studied
As listed on its trial records.
- Influenza
Approved drugs for the same conditions: Influenza · Infectious disease and vaccines
Largest trials
Live from ClinicalTrials.gov: studies naming "TRX-100" as an intervention, largest first.
- Phase 2a Study of the Efficacy and Safety of TRX-100 in a Human Influenza A Challenge ModelPivotal-lookingNot yet recruiting
Traws Pharma, Inc.Industry
NCT07503405 · 165 participants (planned) · Start Jun 2026 · Primary completion Nov 2026
Drug: TRX-100; Placebo and 1 more · For: Influenza
Sites: London, United Kingdom
- This is an Early-stage Clinical Trial to Determine a Safe and Effective Dose for Tivoxavir Marboxil in Patients With Mild to Moderate InfluenzaPivotal-lookingActive, not recruiting
Traws Pharma, Inc.Industry
NCT07371650 · 105 participants (planned) · Start Dec 15, 2025 · Primary completion Dec 2026
Drug: TRX-100; Standard of Care (SOC) · For: Influenza
Sites: Charlestown, Australia
Traws Pharma, Inc.Industry
NCT06757738 · 66 participants · Start Aug 13, 2024 · Primary completion Jan 16, 2025
Drug: TRX-100; Placebo · For: Healthy Volunteer Study
Sites: Sydney, Australia
- Study of TRX-100 Evaluating the Safety, Pharmacokinetics, and Food Effect in Healthy VolunteersRecruiting
Traws Pharma, Inc.Industry
NCT07526506 · 32 participants (planned) · Start Mar 25, 2026 · Primary completion Sep 2026
Drug: TRX-100; Placebo · For: Healthy Volunteer
Sites: Randwick, Australia
Newest research
PubMed records naming it or its code names, newest first.
- Effect of Doum (Hyphaene thebaica) mesocarp and endosperm extracts on Triton X-100 induced hyperlipidemic rat: mitigative cardiovascular and renal dysfunction risks.
Almezail MS, Alhomaid RM · Front Nutr 2026
- Acidic pH irreversibly activates the signaling enzyme SARM1.
Zhao YJ, He WM, Zhao ZY, et al. · FEBS J 2021
- Troxerutin Prevents 5-Fluorouracil Induced Morphological Changes in the Intestinal Mucosa: Role of Cyclooxygenase-2 Pathway.
de Miranda JAL, Martins CDS, Fideles LS, et al. · Pharmaceuticals (Basel) 2020
- Chemical synthesis of flower-like hybrid Cu(OH)2/CuO electrode: Application of polyvinyl alcohol and triton X-100 to enhance supercapacitor performance.
Shinde SK, Fulari VJ, Kim DY, et al. · Colloids Surf B Biointerfaces 2017
- Stabilizing two IgG1 monoclonal antibodies by surfactants: Balance between aggregation prevention and structure perturbation.
Wang S, Wu G, Zhang X, et al. · Eur J Pharm Biopharm 2017
- Fluorescence quenching of Acridine Orange in microemulsions induced by the non-steroidal anti-inflammatory drug Piroxicam.
Andrade SM, Costa SM · Photochem Photobiol Sci 2003
Also in development for Influenza
- Investigational Influenza VaccinePhase 34 trials
BioNTech SE · Influenza, COVID-19, COVID-19 (Coronavirus Disease 2019)
- GP681Phase 32 trials
Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Influenza, Human, Influenza
- GP681 SimulantPhase 32 trials
Jiangxi Qingfeng Pharmaceutical Co. Ltd. · Influenza, Human, Influenza
- BRC-201TG-1000, Pixavir MarboxilPhase 31 trial
Boryung Biopharma Co., Ltd. · Influenza
- mRNA-1018-H5Phase 31 trial
Moderna · Influenza
- Fluzone QudrivalentPhase 22 trials
Sanofi · Healthy Volunteers, Influenza Immunization, Influenza
- ApomivirFE-L-APO, drug substancePhase 21 trial
Far East Bio-Tec Co., Ltd · Influenza
- OVX836Phase 21 trial
Osivax · Influenza
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.